AMF Tjanstepension AB Purchases Shares of 73,902 Humana Inc. $HUM

Key Points

• AMF Tjanstepension AB acquired 73,902 shares of Humana Inc., valued at approximately $18.07 million, during the 2nd quarter, increasing its ownership to about 0.06% of the company.
• Humana's recent quarterly earnings report showed a miss on EPS estimates while reporting an increase in revenue of 9.6% year-over-year.
• The firm announced a quarterly dividend of $0.885 per share, representing an annualized dividend yield of 1.2% with a payout ratio of 27.17%.

AMF Tjanstepension AB acquired a new position in Humana Inc. (NYSE:HUM - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 73,902 shares of the insurance provider's stock, valued at approximately $18,073,000. AMF Tjanstepension AB owned about 0.06% of Humana as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in HUM. Revolve Wealth Partners LLC acquired a new position in Humana during the fourth quarter worth $202,000. Merit Financial Group LLC raised its holdings in shares of Humana by 343.0% in the 1st quarter. Merit Financial Group LLC now owns 8,058 shares of the insurance provider's stock valued at $2,132,000 after buying an additional 6,239 shares during the period. Riverview Trust Co acquired a new position in Humana during the 1st quarter worth about $34,000. Gateway Investment Advisers LLC boosted its holdings in Humana by 53.4% during the 1st quarter. Gateway Investment Advisers LLC now owns 3,629 shares of the insurance provider's stock valued at $960,000 after acquiring an additional 1,263 shares during the period. Finally, Sivia Capital Partners LLC purchased a new position in Humana during the 1st quarter valued at about $223,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on HUM. Wells Fargo & Company cut their price target on shares of Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a research note on Thursday, August 14th. Bank of America lifted their price objective on shares of Humana from $285.00 to $312.00 and gave the company a "neutral" rating in a report on Tuesday, September 2nd. Barclays reduced their target price on shares of Humana from $315.00 to $245.00 and set an "equal weight" rating on the stock in a report on Friday. Piper Sandler decreased their price target on shares of Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research report on Thursday, July 31st. Finally, Morgan Stanley cut their price objective on Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 31st. Seven equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Humana currently has an average rating of "Hold" and a consensus target price of $291.21.

Humana Trading Up 10.7%

NYSE HUM opened at $284.00 on Friday. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The firm has a 50 day moving average of $274.76 and a two-hundred day moving average of $257.42. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $34.16 billion, a PE ratio of 21.80, a price-to-earnings-growth ratio of 1.51 and a beta of 0.42.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.Humana's revenue for the quarter was up 9.6% on a year-over-year basis. During the same period last year, the firm posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. Humana's dividend payout ratio is presently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.